FDA Panel Clears the Way for 6 Banned Peptides. Here’s What They’re Claimed to Do
The floodgates are expected to open up for several peptides previously restricted by the Food and Drug Administration. This week, an advisory panel assembled by the FDA weighed in on whether compounding pharmacies should be allowed to produce seven peptides currently placed on a banned list. The panel ultimately recommended giving the green light to nearly every peptide up for review over the objection of career scientists at the FDA.
- ▪The floodgates are expected to open up for several peptides previously restricted by the Food and Drug Administration.
- ▪This week, an advisory panel assembled by the FDA weighed in on whether compounding pharmacies should be allowed to produce seven peptides currently placed on a banned list.
- ▪The panel ultimately recommended giving the green light to nearly every peptide up for review over the objection of career scientists at the FDA.
Gizmodo files mainly under tech. We currently carry 457 of its stories.
Opening excerpt (first ~120 words) tap to expand
The floodgates are expected to open up for several peptides previously restricted by the Food and Drug Administration. This week, an advisory panel assembled by the FDA weighed in on whether compounding pharmacies should be allowed to produce seven peptides currently placed on a banned list. The panel ultimately recommended giving the green light to nearly every peptide up for review over the objection of career scientists at the FDA. With these unapproved drugs set to be more widely available than ever before, here’s what you should know about…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Gizmodo.